previou
virolog
immunolog
studi
suggest
multipl
sclerosi
ms
autoimmun
diseas
trigger
viru
infect
order
inhibit
growth
measl
viru
patient
jejunum
obtain
igarich
cow
colostrum
contain
antimeasl
lactoglobulin
resist
proteas
colostrum
oral
administ
patient
ms
investig
effect
cours
diseas
measlesposit
antibodi
colostrum
oral
administ
everi
morn
patient
ms
daili
dosag
ml
day
similarli
measlesneg
antibodi
control
colostrum
oral
administ
patient
clinic
assess
disabl
score
develop
intern
feder
multipl
sclerosi
societi
use
result
high
nt
titr
antimeasl
colostrum
recipi
patient
improv
remain
unchang
among
low
nt
titr
antimeasl
colostrum
recipi
patient
improv
remain
unchang
howev
neg
nt
titr
colostrum
recipi
patient
remain
unchang
worsen
sideeffect
observ
colostrum
recipi
find
suggest
efficaci
oral
administ
antimeasl
colostrum
improv
condit
ms
patient
follow
method
prasad
et
al
abl
rescu
measl
viru
antigen
jejunum
multipl
sclerosi
ms
patient
clinic
stabl
state
cell
fusion
techniqu
use
polyethylen
glycol
hypothes
manifest
measl
viru
iejunum
cell
certain
time
probabl
exacerb
unknown
mechan
result
infect
nascent
tlymphocyt
modif
tcell
membran
modifi
tlymphocyt
recogn
foreign
bodi
antimodifi
tlymphocyt
sera
produc
ebina
et
al
autoantibodi
autoantibodi
frequent
found
sera
ms
patient
exacerb
state
prove
detect
lymphocytotox
antibodi
patient
cell
membran
tlymphocyt
share
common
antigen
human
brain
tissu
like
virusinduc
lymphocytotox
antibodi
would
crossreact
brain
cell
membran
lead
immunopatholog
demyelin
central
nervou
system
ms
patient
propos
briefli
ms
autoimmun
deseas
trigger
viru
infect
purpos
paper
confirm
hypothesi
develop
new
treatment
ms
therefor
order
inhibit
growth
measl
viru
patient
jejunum
exacerb
obtain
lgarich
colostrum
contain
antimeasl
neutral
antibodi
resist
proteas
oral
administ
patient
ms
prepar
antimeasl
cow
colostrum
eightmonthpregn
holstein
cow
immun
subcutan
schwarz
strain
measl
viru
ml
x
ml
time
loday
interv
calv
colostrum
collect
first
day
immedi
cool
store
butter
fat
remov
cream
separ
bacteria
red
blood
cell
remov
three
centrifug
g
rain
colostr
nonfat
milk
check
bacteria
less
e
coli
approv
drink
sendai
municip
institut
hygien
frozen
unit
administr
purif
ofimmunoglobulin
cow
colostrum
casein
remov
acid
precipit
ph
colostr
whey
appli
deae
cellulos
column
x
cm
elut
phosphat
buffer
ph
fraction
assay
bovin
igg
bovin
lga
singl
radial
immunodiffus
use
antibovin
serum
lgg
antibovin
serum
lga
mile
laboratori
inc
usa
rechromatographi
de
prepar
contain
igg
appli
sephadex
column
x
cm
elut
trishcl
buffer
ph
contain
rechromatographi
purifi
lgg
final
obtain
prepar
contain
igg
reappli
column
iga
fraction
appli
protein
affin
column
elut
phosphat
buffer
ph
gel
filtrat
purifi
lga
final
obtain
purifi
igg
iga
show
singl
precipit
band
agar
diffus
patient
includ
studi
patient
male
femal
age
year
definit
ms
defin
schumach
committe
criteria
durat
diseas
prior
enter
studi
vari
year
clinic
assess
clinic
assess
disabl
score
adopt
intern
feder
multipl
sclerosi
societi
ifmss
list
minim
record
disabl
use
minim
record
disabl
contain
data
comparison
made
one
ms
centr
anoth
one
countri
anoth
multipl
sclerosi
minim
record
disabl
consist
five
section
demograph
inform
function
system
disabl
statu
scale
ms
incapac
statu
environment
statu
report
data
function
system
disabl
statu
scale
use
evalu
function
system
rate
base
result
standard
neurolog
examin
pyramid
eerebellar
brainstem
sensori
bowel
bladder
visual
mental
function
disabl
statu
scale
score
base
function
system
rate
scale
neutral
antibodi
nt
titrc
cow
colostrum
measl
viru
hal
titr
cow
serum
given
tabl
nt
titr
measur
use
edmonston
strain
measl
veto
cell
also
tabl
show
content
iga
lgg
colostr
nonfat
milk
clear
day
colostrum
contain
greatest
amount
laetoglobulin
highest
nt
titr
compar
day
colostrum
market
milk
contain
lactoglobulin
neutral
antibodi
measl
viru
therefor
studi
effect
day
colostrum
alter
cours
ms
next
order
character
effect
lg
compon
antimeasl
neutral
antibodi
colostrum
igg
iga
purifi
describ
materi
method
shown
tabl
neutral
activ
igg
iga
measl
viru
edmonston
strain
respect
therefor
seem
neutral
activ
igg
colostrum
quantit
depend
tabl
iga
import
qualit
inhibit
measl
viru
growth
jejunum
stabil
colostrum
neutral
activ
proteas
report
previou
paper
treatment
trypsin
h
affect
neutral
titr
three
kind
cow
colostrum
use
high
nt
titr
measl
viru
low
nt
titr
measl
viru
neg
nt
titr
measl
viru
total
ms
patient
oral
given
ml
igarich
colostrum
everi
morn
day
patient
chang
disabl
score
oral
administr
colostrum
compar
shown
tabl
high
nt
titr
antimeasl
colostrum
recipi
patient
improv
remain
unchang
summar
tabl
antimeasl
colostrum
significantli
improv
condit
ms
patient
p
aetiolog
ms
still
unknown
specif
treatment
steroid
hormon
commonli
use
exacerb
sever
sideeffect
jacob
et
al
report
intrathec
interferon
reduc
exacerb
ms
serial
lumber
inject
interferon
pain
mertin
et
al
report
margin
benefici
effect
immunosuppress
azathiopurin
antilymphocyt
globulin
prednisolon
especi
effect
patient
howev
immunosuppress
treatment
also
caus
variou
sideeffect
hand
oral
colostrum
administr
caus
sideeffect
present
data
show
colostr
nonfat
milk
contain
lactoglobulin
nt
titr
measl
viru
seem
hinder
clinic
cours
ms
recent
watanab
et
al
report
infect
rat
murin
coronaviru
jhm
led
develop
demyelin
encyphalomyel
sever
week
month
post
infect
lymphocyt
diseas
lewi
rat
restimul
basic
myelin
protein
adopt
transfer
cell
led
lesion
resembl
experiment
allerg
encephalomyel
recipi
model
demonstr
viru
infect
cn
tissu
capabl
initi
autoimmun
respons
may
pathogen
import
would
like
propos
ms
also
autoimmun
diseas
trigger
morbilliviru
infect
small
intestin
